Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Ceapro Inc V.CZO

Chemicals Specialty Chemicals
Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human... see more

Recent & Breaking News (TSXV:CZO)

Ceapro Inc. Announces Positive Data from Bioavailability Studies Evaluating CoQ10 Formulations Impregnated with PGX-Processed Carriers

GlobeNewswire October 13, 2022

Ceapro Inc. Reports Record 2022 Second Quarter and Six-Month Financial Results and Provides Corporate Update

GlobeNewswire August 24, 2022

Ceapro Inc. Expands Collaborative Research Program with McMaster University to Develop an Inhalable Immuno-Therapeutic/-Prophylactic for COVID-19-Induced Lung Fibrosis

GlobeNewswire August 11, 2022

Ceapro (TSXV:CZO) publishing strong PGX tech results

Caroline Egan  August 9, 2022

Ceapro Inc. Announces Publication of Positive Results for PGX-Processed Alginates Impregnated with CoQ10 in The Journal of Supercritical Fluids

GlobeNewswire August 9, 2022

Ceapro Bolsters Executive Management Team with Appointment of Sigrun Watson as Chief Revenue Officer

GlobeNewswire July 12, 2022

Ceapro Announces Results of 2022 Shareholders' Meeting

GlobeNewswire June 7, 2022

Ceapro Inc. to Present at the H.C. Wainwright Global Investment Conference

GlobeNewswire May 23, 2022

Ceapro Inc. Reports Record Financial Results for First Quarter 2022 and Provides Corporate Update

GlobeNewswire May 18, 2022

Ceapro Inc. Present PGX Enabling Technology Case Study at the 13th International Symposium on Supercritical Fluids

GlobeNewswire May 13, 2022

Ceapro Inc. Announces Publication of Results for PGX-Processed Alginates in the Journal of CO2 Utilization

GlobeNewswire May 11, 2022

Ceapro Inc. Announces Appointment of Geneviève Foster to Board of Directors

GlobeNewswire April 19, 2022

Ceapro Inc. Reports Fourth Quarter and Full Year 2021 Financial Results and Operational Highlights

GlobeNewswire April 13, 2022

Ceapro (TSXV:CZO) signs long-term agreement with Symrise

Trevor Abes  March 10, 2022

Ceapro Signs Exclusive Long-Term Supply and Distribution Agreement with Leading Global Provider of Active Ingredients, Symrise

GlobeNewswire March 10, 2022

Ceapro (TSXV:CZO) appoints top executive from global pharmaceutical industry

Caroline Egan  March 2, 2022

Ceapro Bolsters Board of Directors with Appointment of Top Executive from Global Pharmaceutical Industry

GlobeNewswire March 2, 2022

Ceapro Inc. to Present at the Virtual Investor 2022 Top Picks Conference

GlobeNewswire January 20, 2022

JTC Team to Host Virtual Investor 2022 Top Picks Conference on January 25th, 26th, and 27th

Accesswire January 12, 2022

Ceapro Inc. Announces R&D Funding to Support PGX Technology Project

GlobeNewswire November 29, 2021